Related Experiment Video
Updated: May 23, 2026

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae
Published on: June 13, 2025
Effect of marbofloxacin on Haemophilus parasuis nasal carriage
Carles Vilalta1, Nuria Galofré, Virginia Aragon
1Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus Univ. Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
Abstract:
Haemophilus parasuis is a colonizer of the upper respiratory tract and the causative agent of Glässer's disease in swine. This study focused on the nasal carriage of H. parasuis after treatment with marbofloxacin. Three marbofloxacin treatments (three doses of 2mg/kg body weight [bw] every 24h, two doses of 4 mg/kg bw every 48 h and 8 mg/kg bw in one single shot) were used and all of them reduce significantly (p<0.05) the nasal carriage of H. parasuis as compared to control animals. Moreover, H. parasuis was not detected in the nasal cavities of piglets after administering the highest dose. The effect of a dose of 8 mg marbofloxacin/kg bw in one shot was further studied in a farm with clinical cases of Glässer's disease using a longitudinal study. Statistically significant reduction of nasal carriage of H. parasuis was detected during the first week after treatment in comparison with the control group. However, a clear relationship between the minimum inhibitory concentration (MIC) of the different strains, their putative virulence or the treatment group (antibiotic or control) from which they were isolated was not detected. Finally, the effect induced by the antibiotic treatment on the bacterial strains seemed to be transitory, since diverse H. parasuis strains (with high and low marbofloxacin MICs) were observed 7 days after finishing the treatment.
Insights
Marbofloxacin significantly reduces nasal carriage of Haemophilus parasuis in swine. However, the antibiotic
Area of Science:
- Veterinary Microbiology
- Animal Health
- Antimicrobial Resistance
Background:
- Haemophilus parasuis is a key respiratory tract colonizer and causes Glässer's disease in swine.
- Understanding the efficacy of antimicrobials like marbofloxacin against H. parasuis nasal carriage is crucial for disease control.
Purpose of the Study:
- To evaluate the impact of different marbofloxacin treatment regimens on the nasal carriage of H. parasuis in piglets.
- To assess the duration of the antimicrobial effect and potential development of resistance.
Main Methods:
- Three marbofloxacin treatment protocols were administered to piglets: 2mg/kg every 24h, 4mg/kg every 48h, and a single 8mg/kg dose.
- Nasal carriage of H. parasuis was monitored and compared to control groups.
- A longitudinal study on a farm with clinical Glässer's disease investigated the 8mg/kg dose's effect.
Main Results:
- All marbofloxacin treatments significantly reduced H. parasuis nasal carriage compared to controls (p<0.05).
- The highest dose (8mg/kg) resulted in no detectable H. parasuis in nasal cavities immediately post-treatment.
- A significant reduction in nasal carriage was observed in the first week post-treatment, but diverse strains reappeared after 7 days.
Conclusions:
- Marbofloxacin is effective in reducing H. parasuis nasal carriage in swine, with higher doses showing more immediate impact.
- The antimicrobial effect appears transient, with bacterial strains re-emerging after treatment cessation.
- No clear correlation was found between MICs, virulence, and treatment outcomes, suggesting complex dynamics in carriage.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Microbiota of the Respiratory Tract
Inhibitors of Bacterial DNA Synthesis
Antimicrobial Effectiveness
Bacterial Meningitis II: Pathophysiology
